P
Protagonist Therapeutics D
D
PTGX
92.430
USD
-3.10
(-3.25%)
مغلق
حجم التداول
48,162
الربح لكل سهم
4
العائد الربحي
-
P/E
-45
حجم السوق
5,897,839,620
المقالات
العنوان: Protagonist Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.